🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsInternationalUK NHS GLP-1 prescribing — NICE TA875 and access guide Page 2

UK NHS GLP-1 prescribing — NICE TA875 and access guide

LondonLisa Mon, Jun 8, 2026 at 12:39 AM 7 replies 149 viewsPage 2 of 2
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
Jun 8, 2026 at 3:29 AM#6

Just to add the Wales perspective — we're on a completely different system. Welsh Government commissioned a separate review and semaglutide for obesity is not yet approved by AWMSG (All Wales Medicines Strategy Group). Our Tier 3 services don't prescribe it at all currently.

Scotland is ahead of England actually — the SMC approved it in 2024 and some NHS boards are already prescribing through their weight management pathways with waits of 4-6 months.

Devolution means four completely different systems for the same drug. Madness.

Last edited: Jun 8, 2026 at 5:29 AM
4 24PharmHunterJen, TomTeleRx, DoseLogDan and 1 other
Reply Quote Save Share Report
steve_okc
Member
489
2,123
Jul 2024
Oklahoma City, OK
Jun 8, 2026 at 3:46 AM#7

One more thing — check if your area has the NHS Wegovy pilot programme. It launched in parts of London, Manchester, and the Midlands in late 2025. Patients in the pilot get fast-tracked (2-4 week wait) and get free behavioural support alongside the medication.

I don't think Leeds is in the pilot yet, but it's expanding. Novo Nordisk is partly funding it as a real-world evidence study.

3 24JakeSmashed95, NauseaFreeNow, SteveThurs
Reply Quote Save Share Report
SallyK_inj
Member
567
2,345
Jul 2024
Iowa
Jun 8, 2026 at 4:03 AM#8

This is all incredibly helpful. I'm going to:

  1. Check the pilot programme — fingers crossed
  2. Book a private endocrinologist consultation and try the shared-care route mentioned
  3. Keep the Tier 3 referral active as a backup

The idea that I have to wait 16 months with a BMI of 38, diabetes, and hypertension while the drug is literally approved and sitting in pharmacies is just absurd. But at least there are workarounds. Will update the thread.

8 2oliver_london, tane_welly, Dr.PathRoch and 5 others
Reply Quote Save Share Report

Similar Threads

EU EMA compounding guidance — 2026 regulatory update9 replies
Australian TGA scheduling changes — peptide access 20268 replies
Canadian GLP-1 coverage — provincial formulary comparison6 replies
Purchasing GLP-1 in Mexico — legality, quality, and safety concerns6 replies
UK Boots Wegovy availability — patient experience thread17 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register